Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147

In the randomized phase III trial N0147 for resected colon cancer, the early trial versions included treatment arms of FOLFIRI (irinotecan, 5-fluorouracil, and leucovorin) with and without cetuximab, in addition to FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin) with and without cetuximab. In t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Huang, Jocelin, Nair, Suresh G., Mahoney, Michelle R., Nelson, Garth D., Shields, Anthony F., Chan, Emily, Goldberg, Richard M., Gill, Sharlene, Kahlenberg, Morton S., Quesenberry, James T., Thibodeau, Stephen N., Smyrk, Thomas C., Grothey, Axel, Sinicrope, Frank A., Webb, Thomas A., Farr, Gist H., Pockaj, Barbara A., Berenberg, Jeffrey L., Mooney, Margaret, Sargent, Daniel J., Alberts, Steven R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4019685/
https://ncbi.nlm.nih.gov/pubmed/24512953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2013.12.002
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi